PG

Procter & Gamble Company
D

PG

Arincen73/100B

Procter & Gamble Company financials

Yes. Procter & Gamble Company earned 16.03B USD of net income over the last twelve months, 18.2% of its revenue. It made a profit in 40 of its 41 fiscal years since 1986. Its last loss was in fiscal year 1993.

Revenue (TTM)
87.92B USD
Net income (TTM)
16.03B USD
Free cash flow (TTM)
15.34B USD
Cash and short-term investments
15.37B USD
Total debt
38.93B USD
Shareholders' equity
55.10B USD

Cash, debt and equity as of 30 Sept 2026.

Procter & Gamble Company earnings

Next earnings · Q2 FY2027
EPS estimate
1.81 USD
Revenue estimate
22.85B USD
Last quarter · Q1 FY2027
EPS2.00Beat +6.4%Revenue23.28BBeat +2.1%

Revenue

ReportedEstimate

EPS

ReportedEstimate
PeriodReport dateEPS estimateReported EPSSurpriseEPS growthRevenue estimateReported revenueSurpriseRevenue growth
Q1 FY20282.10——+5.19%24.04B——+3.28%
Q4 FY20271.53——+7.08%22.03B——+3.92%
Q3 FY20271.63——+2.71%21.80B——+2.66%
Q2 FY20271.81——-3.72%22.85B——+2.90%
Q1 FY20271.882.00+6.38%+0.50%22.80B23.28B+2.11%+3.98%
Q4 FY20261.411.43+1.42%-3.38%21.38B21.20B-0.83%+1.50%
Q3 FY20261.561.59+1.92%+3.25%20.53B21.24B+3.43%+7.38%
Q2 FY20261.861.88+1.08%0.00%22.30B22.21B-0.40%+1.49%
Q1 FY20261.901.99+4.74%+3.11%22.18B22.39B+0.92%+2.99%
Q4 FY20251.421.48+4.23%+5.71%20.84B20.89B+0.23%+1.74%

Procter & Gamble Company growth and profitability

Full income statement
Revenue (TTM)
87.92B USD
Net income (TTM)
16.03B USD
Gross margin
49.78%
Operating margin
22.55%
Net margin
18.23%

Revenue / Net income

Revenue Net income Net margin
PeriodRevenueGrowthNet incomeGrowthGross marginOperating marginNet marginEBITDAGrowth
FY202687.03B+3.26%16.05B+0.45%50.18%22.69%18.44%24.41B+2.06%
FY202584.28B+0.29%15.97B+7.36%51.16%24.26%18.95%23.92B+5.93%
FY202484.04B+2.48%14.88B+1.54%51.39%22.07%17.70%22.58B+3.73%
FY202382.01B+2.27%14.65B-0.60%47.86%22.11%17.87%21.77B+2.50%
FY202280.19B+5.35%14.74B+3.05%47.43%22.21%18.38%21.24B+1.87%

How Procter & Gamble Company makes its money

Revenue87.03B 100.0%
Cost of revenue43.36B 49.8%
Gross profit43.67B 50.2%
Selling and administration23.92B 27.5%
Operating income19.75B 22.7%
Tax4.23B 4.9%
Net income16.05B 18.4%

FY2026, in USD. Each band is as wide as its money; the percentage is its share of revenue.

Procter & Gamble Company revenue breakdown

By product

FY2026
Fabric Care And Home Care: 35.2%Baby, Feminine and Family Care: 23.7%Beauty: 18.6%Health Care: 14.5%Grooming: 8.0%35.2%Fabric Care And Home Care23.7%Baby, Feminine and Family Care18.6%Beauty14.5%Health Care8.0%Grooming
SegmentRevenueShare of revenueChange on the year
Fabric Care And Home Care30.31B35.2%+2.4%
Baby, Feminine and Family Care20.40B23.7%+0.8%
Beauty16.02B18.6%+7.1%
Health Care12.46B14.5%+3.8%
Grooming6.92B8.0%+3.8%

By region

FY2026
Non-US: 52.1%United States: 47.9%52.1%Non-US47.9%United States
RegionRevenueShare of revenueChange on the year
Non-US45.30B52.1%+6.1%
United States41.70B47.9%+0.2%

Operating and free cash flow

Full cash flow statement
Operating cash flow Free cash flow
Fiscal yearOperating cash flowFree cash flow
FY202619.56B15.15B
FY202517.82B14.05B
FY202419.85B16.52B
FY202316.85B13.79B
FY202216.72B13.57B
FY202118.37B15.58B
FY202017.40B14.33B
FY201915.24B11.90B
FY201814.87B11.15B
FY201712.75B9.37B

Procter & Gamble Company financial health

Full balance sheet
Cash and short-term investments
15.37B USD
Total debt
38.93B USD
Net cash
-23.56B USD
Free cash flow (TTM)
15.34B USD
Current ratio
0.72
Debt to equity
0.71
Piotroski score
8 / 9
Altman Z-score
5.42

Cash, debt and free cash flow

Cash and short-term investments Total debt Free cash flow
Fiscal yearCash and short-term investmentsTotal debtFree cash flow
FY20269.94B35.03B15.15B
FY20259.56B35.46B14.05B
FY20249.48B33.37B16.52B
FY20238.25B35.42B13.79B
FY20227.21B32.29B13.57B

Assets, liabilities and equity

Total assets Total liabilities Shareholders' equity
Fiscal yearTotal assetsTotal liabilitiesShareholders' equity
FY2026126.52B72.21B54.31B
FY2025125.23B72.95B52.01B
FY2024122.37B71.81B50.29B
FY2023120.83B73.76B46.78B
FY2022117.21B70.35B46.59B
FY2021119.31B72.65B46.38B
FY2020120.70B73.82B46.52B
FY2019115.10B67.52B47.19B
FY2018118.31B65.43B52.29B
FY2017120.41B64.63B55.18B

Procter & Gamble Company valuation

Price to earnings ratio (TTM)
24.50
Forward P/E (FY2027)
23.71
Price to sales (TTM)
4.36
Price to book
6.96
EV / EBITDA (TTM)
16.62

Capital structure

Market capitalization
383.34B USD
+
Total debt
38.93B USD
−
Cash and short-term investments
15.37B USD
=
Enterprise value
406.90B USD

Valuation over time

P/EForward P/EForward P/E · EstimateEstimate
Fiscal yearP/EForward P/EP/SP/BEV/EBITDA
FY2029 (est.)21.06————
FY2028 (est.)22.3421.06———
FY2027 (est.)23.7122.34———
Now (TTM)24.5023.194.366.9616.62
FY202621.7221.004.086.5415.58
FY202523.8923.174.647.5217.43
FY202426.3324.344.577.6418.06
FY202325.0025.504.387.6817.75
FY202223.9724.584.417.5817.81

Procter & Gamble Company against its own history

Each figure in the latest fiscal year against the same figure from FY2022 to FY2026: the range, its median (the line) and the latest (the dot, green on the good side of the median). The P/E is today's against its daily readings of five years.

Its peers: The Coca-Cola, Philip Morris International, Costco Wholesale, PepsiCo, Walmart, and Altria Group, the US Consumer Defensive companies closest to it in size, each in its own latest fiscal year: their median (the line) and its rank among them, first being the best.

  • P/E (today)Below its median24.5
    19.630.2
  • Gross marginAt its median50.2%
    47.4%51.4%
    Against its peers: 5 of 7Peers' median 57.9%
  • Operating marginAbove its median22.7%
    22.1%24.3%
    Against its peers: 4 of 7Peers' median 20.5%
  • Net marginAbove its median18.4%
    17.7%19.0%
    Against its peers: 4 of 7Peers' median 18.1%
  • Return on equityLowest in 5 years29.5%
    29.5%31.6%
    Against its peers: 3 of 5Peers' median 33.1%
  • Free cash flow marginAbove its median17.4%
    16.7%19.7%
    Against its peers: 3 of 7Peers' median 9.6%
  • Revenue growthAbove its median3.3%
    0.3%5.3%
    Against its peers: 4 of 7Peers' median 3.5%
  • EPS growthBelow its median1.7%
    1.5%8.1%
    Against its peers: 5 of 7Peers' median 13.6%
  • Debt to EBITDALowest in 5 years1.43×
    1.43×1.63×
    Against its peers: 2 of 7Peers' median 2.45×
  • Current ratioAt its median0.68
    0.630.73
    Against its peers: 6 of 7Peers' median 0.91

Peers: US companies of the same industry (of its sector when the industry has too few) from a tenth to ten times its market value, the six closest in size. Updated weekly.

Procter & Gamble Company dividends

Annual dividend
4.35 USD
Dividend yield (indicated)
2.63%
Payout ratio
64.03%
Years of dividend growth
43
Frequency
Quarterly
Next payment
1.09 USD
Last ex-dividend date
23 Oct 2026
Next payment date
16 Nov 2026

Dividends per share

Year2025202420232022202120202019201820172016
Dividends per share4.183.963.743.613.403.122.952.842.742.67

Procter & Gamble Company ownership

Institutions
69.24%
Institutional holders
4,154 (+36)
Free float
99.93%

Who owns the shares

Institutions 69.2% Others 30.8%
As of 30 Jun 2026

Shares free to trade

Free float 2.32B shares ·99.9% Closely held 1.66M shares ·0.1%

Closely held shares belong to insiders, founders and owners of more than 5%, and seldom change hands. The free float is the rest: the shares anyone can buy and sell.

Insider trading

QuarterPurchasesSalesShares acquiredShares disposed of
Q4 2026010784.33K223.00K
Q3 2026015163.10K46.51K
Q2 2026002.00K0.00
Q1 2026012335.17K681.88K

Shares outstanding

Basic shares Diluted shares Change in diluted shares
Fiscal yearBasic sharesDiluted sharesChange in diluted shares
FY20262.42B2.42B-1.30%
FY20252.45B2.45B-0.71%
FY20242.36B2.47B-0.48%
FY20232.37B2.48B-2.17%
FY20222.46B2.54B-2.38%

Common questions about Procter & Gamble Company's financials

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.